CCL2 and liver dysplastic nodule: Other research has shown that once MCP-1 is secreted, it can diffuse back to the podocyte and act in a loop by activating the CCR2 receptor, which then initiates profound biological effects [11], suggesting podocytes as a potential target of inflammation in DN.